Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SHILPA MEDICARE LTD

  • FDA Approval
  • Aug. 27, 2024, 21:10 UTC
  • 29
  • 0 comments

FDA approve BORTEZOMIB

Comment Full text

PF PRISM CV

  • FDA Approval
  • Aug. 27, 2024, 21:10 UTC
  • 25
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text

ACTAVIS

  • FDA Approval
  • Aug. 27, 2024, 21:10 UTC
  • 29
  • 0 comments

FDA approve DOCETAXEL

Comment Full text

BIOMARIN PHARM

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 18
  • 0 comments

FDA approve SAPROPTERIN DIHYDROCHLORIDE

Comment Full text

ACTAVIS MID ATLANTIC

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 24
  • 0 comments

FDA approve MESALAMINE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 22
  • 0 comments

FDA approve FINASTERIDE

Comment Full text

RISING

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 23
  • 0 comments

FDA approve INDAPAMIDE

Comment Full text

RISING

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 27
  • 0 comments

FDA approve NADOLOL

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 23
  • 0 comments

FDA approve TEMOZOLOMIDE

Comment Full text

TEVA

  • FDA Approval
  • Aug. 27, 2024, 08:47 UTC
  • 20
  • 0 comments

FDA approve CARVEDILOL

Comment Full text
  • Previous
  • 273
  • 274
  • 275
  • 276
  • 277
  • Next

Search

News categories

  • Technical Exchange News(9977)
  • Event(412)
  • SEC News(168967)
  • FDA Approval(9382)
  • Company Report(721)
  • Business News(112614)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin